Microfluidic heart on a chip for higher throughput pharmacological studies

被引:371
作者
Agarwal, Ashutosh [1 ]
Goss, Josue Adrian [1 ]
Cho, Alexander [1 ]
McCain, Megan Laura [1 ]
Parker, Kevin Kit [1 ]
机构
[1] Harvard Univ, Sch Engn & Appl Sci, Harvard Stem Cell Inst, Dis Biophys Grp,Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA
关键词
CELL-DERIVED CARDIOMYOCYTES; CARDIAC MYOCYTE; DRUG DISCOVERY; IN-VITRO; CONTRACTILITY; MUSCLE; CARDIOTOXICITY; INHIBITION; MECHANICS; DEVICES;
D O I
10.1039/c3lc50350j
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We present the design of a higher throughput "heart on a chip'' which utilizes a semi-automated fabrication technique to process sub millimeter sized thin film cantilevers of soft elastomers. Anisotropic cardiac microtissues which recapitulate the laminar architecture of the heart ventricle are engineered on these cantilevers. Deflection of these cantilevers, termed Muscular Thin Films (MTFs), during muscle contraction allows calculation of diastolic and systolic stresses generated by the engineered tissues. We also present the design of a reusable one channel fluidic microdevice completely built out of autoclavable materials which incorporates various features required for an optical cardiac contractility assay: metallic base which fits on a heating element for temperature control, transparent top for recording cantilever deformation and embedded electrodes for electrical field stimulation of the tissue. We employ the microdevice to test the positive inotropic effect of isoproterenol on cardiac contractility at dosages ranging from 1 nM to 100 mu M. The higher throughput fluidic heart on a chip has applications in testing of cardiac tissues built from rare or expensive cell sources and for integration with other organ mimics. These advances will help alleviate translational barriers for commercial adoption of these technologies by improving the throughput and reproducibility of readout, standardization of the platform and scalability of manufacture.
引用
收藏
页码:3599 / 3608
页数:10
相关论文
共 38 条
[1]   Engineering design of a cardiac myocyte [J].
Adams, W. J. ;
Pong, T. ;
Geisse, N. A. ;
Sheehy, S. P. ;
Diop-Frimpong, B. ;
Parker, K. K. .
JOURNAL OF COMPUTER-AIDED MATERIALS DESIGN, 2007, 14 (01) :19-29
[2]   Vascular smooth muscle contractility depends on cell shape [J].
Alford, Patrick W. ;
Nesmith, Alexander P. ;
Seywerd, Johannes N. ;
Grosberg, Anna ;
Parker, Kevin Kit .
INTEGRATIVE BIOLOGY, 2011, 3 (11) :1063-1070
[3]   Biohybrid thin films for measuring contractility in engineered cardiovascular muscle [J].
Alford, Patrick W. ;
Feinberg, Adam W. ;
Sheehy, Sean P. ;
Parker, Kevin K. .
BIOMATERIALS, 2010, 31 (13) :3613-3621
[4]  
Boudou T, 2012, TISSUE ENG PT A, V18, P910, DOI [10.1089/ten.tea.2011.0341, 10.1089/ten.TEA.2011.0341]
[5]   Nuclear morphology and deformation in engineered cardiac myocytes and tissues [J].
Bray, Mark-Anthony P. ;
Adams, William J. ;
Geisse, Nicholas A. ;
Feinberg, Adam W. ;
Sheehy, Sean P. ;
Parker, Kevin K. .
BIOMATERIALS, 2010, 31 (19) :5143-5150
[6]   Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations [J].
Cohen, J. D. ;
Babiarz, J. E. ;
Abrams, R. M. ;
Guo, L. ;
Kameoka, S. ;
Chiao, E. ;
Taunton, J. ;
Kolaja, K. L. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2011, 257 (01) :74-83
[7]   Reducing the costs of phase III cardiovascular clinical trials [J].
Eisenstein, EL ;
Lemons, PW ;
Tardiff, BE ;
Schulman, KA ;
Jolly, MK ;
Califf, RM .
AMERICAN HEART JOURNAL, 2005, 149 (03) :482-488
[8]  
Esch MB, 2011, ANNU REV BIOMED ENG, V13, P55, DOI [10.1146/annurev-bioeng-071910-124629, 10.1146/annurev-biocng-071910-124629]
[9]  
Fajardo G, 2008, CIRCULATION, V118, pS485
[10]   Muscular thin films for building actuators and powering devices [J].
Feinberg, Adam W. ;
Feigel, Alex ;
Shevkoplyas, Sergey S. ;
Sheehy, Sean ;
Whitesides, George M. ;
Parker, Kevin Kit .
SCIENCE, 2007, 317 (5843) :1366-1370